Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Piper Jaffray Downgrades Mirati Therapeutics (MRTX) to Neutral
September 17, 2015 6:50 AM EDTPiper Jaffray downgraded Mirati Therapeutics (NASDAQ: MRTX) from Overweight to Neutral with a price target of $45.00 (from $50.00).
Analyst Charles Duncan commented, "Mirati management took advantage of recent share price performance and bolstered its balance sheet and thus we have updated our model for... More
Mirati Therapeutics (MRTX) Prices 2.25M Common Stock Offering at $45/Share
September 16, 2015 6:57 AM EDTMirati Therapeutics (NASDAQ: MRTX) announced the pricing of an underwritten public offering of 2,250,000 shares of its common stock at a price to the public of $45.00 per share. The gross proceeds from this offering are expected to be approximately $101.3 million, before deducting underwriting discounts and... More
